-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
-
Gladstone Alternative Income Fund Announces Monthly Cash Distribution for November 2026
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
-
With Expansion into Naval Shipbuilding, Hanwha Philly Shipyard Names 25-Year Shipbuilding Veteran as President
-
ASGA's Attack on Menhaden Science Exposes Its Own Double Standard
-
Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month
-
Hop-on (OTCID: HPNN) Subsidiary Digitalage Completes Core Cre-ator Platform Build, Moves to Enterprise Technology Licensing
Fourth jab 'partially' effective against Omicron: Israeli study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
A team from Sheba Medical Center near Tel Aviv began conducting a trial in December on fourth doses of coronavirus vaccines, inoculating 154 hospital personnel with Pfizer jabs and 120 other volunteers with Moderna doses.
Preliminary results of the trial "have shown that the vaccines are safe and have shown to produce substantial antibodies, but are only partially effective in defending against the Omicron variant," the hospital said in a statement.
Professor Gili Regev-Yochay, who leads the study, said that while there was an increase in antibodies after administering a fourth dose, it nonetheless "only offers a partial defenser against the virus" for those infected with the Omicron variant.
The vaccines were "extremely effective against the earlier variants," Regev-Yochay noted.
Israel was among the first countries to launch mass immunisation campaigns for its population.
It then began offering booster shots last summer, and has since greenlighted fourth shots for elderly and vulnerable populations.
More than 537,000 Israelis have received a fourth dose of vaccine, according to the health ministry's latest figures.
More than 80 percent of Israel's adult residents have received two coronavirus vaccine shots and more than half have also been given a booster.
- Reduced quarantine -
Meanwhile, the Israeli government on Monday said it was reducing the quarantine period for positive cases from seven to five days, as a record number of infections threatens to overburden the economy.
"This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult," Prime Minister Naftali Bennett said in a short video message sent by his office.
Faced with skyrocketing infections fuelled by the Omicron variant, Israel has become the latest country to reduce quarantine periods, after similar moves from France, Spain, Argentina, the United States and Britain.
Israel shuttered its borders after discovering one case infected with the Omicron variant in November, but reopened in early January, despite a spike in infections.
In total, more than 1.7 million infections have been recorded since the start of the pandemic in Israel, including more than 8,300 deaths, according to official figures.
O.M.Souza--AMWN